PRESS RELEASES
UPCOMING EVENTS
Learn more about our unique first-in-class lead compound SCO-101
Positive topline Phase IIa data
Positive topline Phase IIa data from the CORIST part 3 trial
WatchLATEST PRESENTATIONS
A great place to work
For talented, ambitious individuals who share our passion for science and drug development, we offer an exciting work environment, along with the opportunity to make a difference for the many cancer patients in need for novel treatments
Read more